机译:A genetic off‐target event in a site‐specific integration cell line expressing monoclonal antibody has no impact on commercial suitability
Biotherapeutics Pharmaceutical Sciences, Pfizer Inc.;
commercial cell line; genetic rearrangement; genotypic consistency; monoclonal antibody; phenotypic stability; site‐specific integration;